Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 243.61 USD -0.27% Market Closed
Market Cap: 35.8B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Operating Income
$1.4B
CAGR 3-Years
14%
CAGR 5-Years
19%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%

See Also

What is Resmed Inc's Operating Income?
Operating Income
1.4B USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Operating Income amounts to 1.4B USD.

What is Resmed Inc's Operating Income growth rate?
Operating Income CAGR 10Y
13%

Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for Resmed Inc have been 14% over the past three years , 19% over the past five years , and 13% over the past ten years .

Back to Top